GLPwatch
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
NCT00937079 · Completed
Last updated 2026-05-28This clinical trial tests a new imaging method using a radioactive tracer to detect insulinomas in patients with hypoglycemia or hyperinsulinism.
Status Completed The study has finished.
Type Observational
Participants 30 people
Who can join Ages 18–90 · all sexes
Timeline Started 2007-11 · est. completion 2011-12
Where 1 site · Switzerland
What this study is testing ClinicalTrials.gov NCT00937079 ↗
Description as written by the study sponsor.
The purpose of this study is to determine whether the investigators' new imaging modality (111In-exendin-4) has advantages in detecting insulinomas in comparison to conventional imaging.
Treatments tested
- 111In-exendin-4 imaging Other
90-100 megabecquerel (MBq) (30 microgram or less) 111In-exendin-4 IV once
| Main thing measured | Detection of insulinomas, cure rate |
|---|---|
| Sponsor | University Hospital, Basel, Switzerland |
| Conditions studied | Hyperinsulinism, Hypoglycemia, Insulinoma |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT00937079 ↗